Transforming Genetic Medicine & Genome Engineering with AI


Genetic Medicine
Develop genetic medicines—safer, smarter, faster—for patients

De-Risk Manufacturing
FormManufacturing™ combines two integrated services to reduce risk and cost from design through commercial release.
Design Vectors that Scale
FormSightAI™ screens thousands of vector designs in silico to identify high-performing candidates upfront, improving yield, reducing contaminants, & lowering COGS.
Defend Every Batch with Confidence
FormBatchQC™ delivers precise, lot-level insight into contaminants and comparability, so teams can defend every batch, streamline filings, and avoid surprises at inspection.

Pipeline
Transforming the genetic medicine pipeline from concept to clinic with AI‑driven design and analysis



Genome Engineering
The company Colossal Biosciences trusts to advance its genome engineering programs
Next-Gen Editing Tools
Leverage breakthroughs in CRISPR and emerging genome engineering technologies to design and optimize precise genetic modifications in any genome.
AI-Powered Analysis
Combine AI-driven insights with expert biological interpretation to identify and validate key genotype-to-phenotype relationships to engineer desired traits.
Accelerate Validation
Validation analysis using amplicon or whole-genome sequencing to measure on-target efficiency and predict impactful off-target effects.

Animal Health
Unlock actionable genome insights for trait discovery, disease prevention & treatment, & breeding

Gene Editing for Trait Enhancement
Optimize CRISPR, base, and prime editing strategies to improve editing efficiency, reduce off-target effects, and accelerate development of high-value traits.
Population Genomics Breeding
Analyze genomic variation across large populations to uncover trait associations, inform breeding decisions, and improve animal health and performance.
Integrated Data Management
Integrate genomic and phenotypic data to support disease surveillance, outbreak and pandemic response (e.g. avian influenza), and feed optimization.
Genomic QC & Characterization
Characterize on-target edits, off-target variants, and genomic changes across generations to support reproducibility, safety, and regulatory readiness.
Applications
Genome Assembly
Accurate reconstruction of genomes to drive discovery in genetics and biology
Genome Reconstruction
Piece together DNA fragments into accurate, contiguous sequences.
Downstream Insights
High quality assemblies that support variant detection, functional annotation, and comparative genomics.

Genome Integrity Analysis
A clear, structured approach for characterizing genetic medicine
Drug Product Insights
Gain a clear view of what’s encapsidated— distribution of full vs. partial genomes and contaminated species.
Truncation Peaks
Mapping truncation hotspots to the vector map uncovers DNA complexities that can be mitigated through data-driven design.

Codon Optimization
An innovative AI technology for reaching effective genetic sequences
Define Program Objectives
Clarify biological goals for optimization, such as boosting protein expression, enhancing manufacturability, and improving safety.
Balancing Tradeoffs
Our model aligns with your goals, optimizing across multiple objectives while managing tradeoffs like increasing expression vs. minimizing truncations.
Optimization & Insights
Leverage Form Bio’s proprietary FORMsightAI model to optimize designs and identify codon substitutions that drive desirable outcomes.

Solutions
Drug Substance Insights
Capsid Analysis
Bioinformatics Analysis
Gene Editing
AI Model Development
Manufacturing Intelligence

Form Bio, the first spinout from Colossal Biosciences (2022), expands foundational multi-species genome engineering technology into human genetic medicines.
We are AI and software engineers, bioinformaticians, molecular and cellular biologists, and drug developers dedicated to accelerating genetic medicine and unlocking breakthroughs that transform health and improve lives.

Leadership Team

Michelle Chen, PhD




Doug Daniels


Joe Nipko, PhD



Amicia Elliott, PhD



Chris Tan, PhD


David Kiger



Angela Anderson



Christina Capehart


Let’s Unlock the Next Breakthrough Together










